Human papillomavirus type 16 E7 oncoprotein associates with E2F6

Journal of Virology

Volumn 82, Issue 17, 2008, Pages 8695-8705

  McLaughlin Drubin, Margaret E ^c   Huh, Kyung Won ^b   Münger, Karl ^a  

^a CHANNING LABORATORY   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; PROTEIN E7; TRANSCRIPTION FACTOR E2F6; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN;

ARTICLE; CELL ACTIVITY; CELL CYCLE S PHASE; CELL FATE; CELLULAR IMMUNITY; CHROMATIN; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIMIAN VIRUS 40; TRANSCRIPTION REGULATION;

ADENOVIRUS E1A PROTEINS; ANTIGENS, VIRAL, TUMOR; CELL CULTURE TECHNIQUES; CELL LINE; E2F TRANSCRIPTION FACTORS; GENES, REPORTER; HELA CELLS; HUMANS; KIDNEY; LUCIFERASES; MODELS, BIOLOGICAL; MUTATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SIMIAN VIRUS 40; TIME FACTORS; TRANSFECTION;

ADENOVIRIDAE; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE; SIMIAN VIRUS 40;

EID: 50149100141     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00579-08     Document Type: Article

References (87)

1. Akasaka, T., M. Kanno, R. Balling, M. A. Mieza, M. Taniguchi, and H. Koseki. 1996. A role for mel-18, a polycomb group-related vertebrate gene, during the anteroposterior specification of the axial skeleton. Development 122:1513-1522.
2. Alkema, M. J., M. Bronk, E. Verhoeven, A. Otte, L. J. van't Veer, A. Berns, and M. van Lohuizen. 1997. Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. Genes Dev. 11:226-240.
3. Alkema, M. J., N. M. van der Lugt, R. C. Bobeldijk, A. Berns, and M. van Lohuizen. 1995. Transformation of axial skeleton due to overexpression of bmi-1 in transgenic mice. Nature 374:724-727.
4. Armstrong, D. J., and A. Roman. 1997. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent. Virology 239:238-246.
5. Attwooll, C., S. Oddi, P. Cartwright, E. Prosperini, K. Agger, P. Steensgaard, C. Wagener, C. Sardet, M. C. Moroni, and K. Helin. 2005. A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner. J. Biol. Chem. 280:1199-1208.
6. Baker, C. C., W. C. Phelps, V. Lindgren, M. J. Braun, M. A. Gonda, and P. M. Howley. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962-971.
7. Baldwin, A., K. W. Huh, and K. Munger. 2006. Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function. J. Virol. 80:6669-6677.
8. Boncinelli, E., A. Mallamaci, and G. Lavorgna. 1994. Vertebrate homeobox genes. Genetica 94:127-140.
9. Campbell, K. S., K. P. Mullane, I. A. Aksoy, H. Stubdal, J. Zalvide, J. M. Pipas, P. A. Silver, T. M. Roberts, B. S. Schaffhausen, and J. A. DeCaprio. 1997. DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication. Genes Dev. 11:1098-1110.
10. Cantile, M., G. Pettinato, A. Procino, I. Feliciello, L. Cindolo, and C. Cillo. 2003. In vivo expression of the whole HOX gene network in human breast cancer. Eur. J. Cancer 39:257-264.
11. Cartwright, P., H. Muller, C. Wagener, K. Holm, and K. Helin. 1998. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 17:611-623.
12. Cermik, D., A. Arici, and H. S. Taylor. 2002. Coordinated regulation of HOX gene expression in myometrium and uterine leiomyoma. Fertil. Steril. 78:979-984.
13. Cheng, S., D. C. Schmidt-Grimminger, T. Murant, T. R. Broker, and L. T. Chow. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:2335-2349.
14. Cillo, C., P. Barba, G. Freschi, G. Bucciarelli, M. C. Magli, and E. Boncinelli. 1992. HOX gene expression in normal and neoplastic human kidney. Int. J. Cancer 51:892-897.
15. Clemens, K. E., R. Brent, J. Gyuris, and K. Munger. 1995. Dimerization of the human papillomavirus E7 oncoprotein in vivo. Virology 214:289-293.
16. Core, N., S. Bel, S. J. Gaunt, M. Aurrand-Lions, J. Pearce, A. Fisher, and M. Djabali. 1997. Altered cellular proliferation and mesoderm patterning in polycomb-M33-deficient mice. Development 124:721-729.
17. Davies, R., R. Hicks, T. Crook, J. Morris, and K. Vousden. 1993. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J. Virol. 67:2521-2528.
18. de Bruin, A., B. Maiti, L. Jakoi, C. Timmers, R. Buerki, and G. Leone. 2003. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J. Biol. Chem. 278:42041-42049.
19. del Mar Lorente, M., C. Marcos-Gutierrez, C. Perez, J. Schoorlemmer, A. Ramirez, T. Magin, and M. Vidal. 2000. Loss- and gain-of-function mutations show a polycomb group function for Ring1A in mice. Development 127:5093-5100.
20. De Vita, G., P. Barba, N. Odartchenko, J. C. Givel, G. Freschi, G. Bucciarelli, M. C. Magli, E. Boncinelli, and C. Cillo. 1993. Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur. J. Cancer 29A:887-893.
21. Dimova, D. K., and N. J. Dyson. 2005. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24:2810-2826.
22. Di Stefano, L., M. R. Jensen, and K. Helin. 2003. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J. 22:6289-6298.
23. Dyson, N., P. Guida, K. Munger, and E. Harlow. 1992. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66:6893-6902.
24. Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
25. Edmonds, C., and K. H. Vousden. 1989. A point mutational analysis of human papillomavirus type 16 E7 protein. J. Virol. 63:2650-2656.
26. Funk, J. O., S. Waga, J. B. Harry, E. Espling, B. Stillman, and D. A. Galloway. 1997. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11:2090-2100.
27. Gaubatz, S., J. G. Wood, and D. M. Livingston. 1998. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl. Acad. Sci. USA 95:9190-9195.
28. Giangrande, P. H., W. Zhu, S. Schlisio, X. Sun, S. Mori, S. Gaubatz, and J. R. Nevins. 2004. A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. Genes Dev. 18:2941-2951.
29. Gould, A. 1997. Functions of mammalian polycomb group and trithorax group related genes. Curr. Opin. Genet. Dev. 7:488-494.
30. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
31. Hinds, P. W., S. F. Dowdy, E. N. Eaton, A. Arnold, and R. A. Weinberg. 1994. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91:709-713.
32. Huh, K., X. Zhou, H. Hayakawa, J. Y. Cho, T. A. Libermann, J. Jin, J. W. Harper, and K. Munger. 2007. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 81:9737-9747.
33. Huh, K. W., J. Demasi, H. Ogawa, Y. Nakatani, P. M. Howley, and K. Munger. 2005. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc. Natl. Acad. Sci. USA 102:11412-11497.
34. Hwang, S. G., D. Lee, J. Kim, T. Seo, and J. Choe. 2002. Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner. J. Biol. Chem. 277:2923-2930.
35. International Agency for Research on Cancer. 1995. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 63. Sons Presse, Lyon, France.
36. Jones, D. L., R. M. Alani, and K. Munger. 1997. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11:2101-2111.
37. Jurgens, G. 1985. A group of genes controlling the spatial expression of the bithorax complex in Drosophila. Nature 316:153-155.
38. La Celle, P. T., and R. R. Polakowska. 2001. Human homeobox HOXA7 regulates keratinocyte transglutaminase type 1 and inhibits differentiation. J. Biol. Chem. 276:32844-32853.
39. Lewis, E. B. 1978. A gene complex controlling segmentation in Drosophila. Nature 276:565-570.
40. Liu, X., A. Clements, K. Zhao, and R. Marmorstein. 2006. Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J. Biol. Chem. 281:578-586.
41. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
42. Lund, A. H., and M. van Lohuizen. 2004. Polycomb complexes and silencing mechanisms. Curr. Opin. Cell Biol. 16:239-246.
43. Lyons, T. E., M. Salih, and B. S. Tuana. 2006. Activating E2Fs mediate transcriptional regulation of human E2F6 repressor. Am. J. Physiol. Cell Physiol. 290:C189-C199.
44. Martens, J. E., J. Arends, P. J. Van der Linden, B. A. De Boer, and T. J. Helmerhorst. 2004. Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell. Anticancer Res. 24:771-775.
45. McGinnis, W., and R. Krumlauf. 1992. Homeobox genes and axial patterning. Cell 68:283-302.
46. Mohar, A., and M. Frias-Mendivil. 2000. Epidemiology of cervical cancer. Cancer Investig. 18:584-590.
47. Morasso, M. I., N. G. Markova, and T. D. Sargent. 1996. Regulation of epidermal differentiation by a Distal-less homeodomain gene. J. Cell Biol. 135:1879-1887.
48. Merkel, M., J. Wenkel, A. J. Bannister, T. Kouzarides, and C. Hagemeier. 1997. An E2F-like repressor of transcription. Nature 390:567-568.
49. Muller, H., M. C. Moroni, E. Vigo, B. O. Petersen, J. Bartek, and K. Helin. 1997. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol. 17:5508-5520.
50. Munger, K., J. R. Basile, S. Duensing, A. Eichten, S. L. Gonzalez, M. Grace, and V. L. Zacny. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898.
51. Munger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
52. Nakatani, Y., and V. Ogryzko. 2003. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 370:430-444.
53. Oberley, M. J., D. R. Inman, and P. J. Farnham. 2003. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. J. Biol. Chem. 278:42466-42476.
54. Ogawa, H., K. Ishiguro, S. Gaubatz, D. M. Livingston, and Y. Nakatani. 2002. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296:1132-1136.
55. Parkin, D. M., P. Pisani, and J. Ferlay. 1999. Global cancer statistics. CA Cancer J. Clin. 55:74-108.
56. Phelps, W. C., C. L. Yee, K. Munger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53:539-547.
57. Piboonniyom, S. O., S. Duensing, N. W. Swilling, J. Hasskarl, P. W. Hinds, and K. Munger. 2003. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res. 63:476-483.
58. Psyrri, A., R. A. DeFilippis, A. P. Edwards, K. E. Yates, L. Manuelidis, and D. DiMaio. 2004. Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res. 64:3079-3086.
59. Ringrose, L., and R. Paro. 2004. Epigenetic regulation of cellular memory by the polycomb and trithorax group proteins. Annu. Rev. Genet. 38:413-443.
60. Saurin, A. J., C. Shiels, J. Williamson, D. P. Satijn, A. P. Otte, D. Sheer, and P. S. Freemont. 1998. The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain. J. Cell Biol. 142:887-898.
61. Schulze, A., B. Mannhardt, K. Zerfass-Thome, W. Zwerschke, and P. Jansen-Durr. 1998. Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16. J. Virol. 72:2323-2334.
62. Schumacher, A., and T. Magnuson. 1997. Murine polycomb- and trithorax-group genes regulate homeotic pathways and beyond. Trends Genet. 13:167-170.
63. Schwartz, Y. B., and V. Pirrotta. 2007. Polycomb silencing mechanisms and the management of genomic programmes. Nat. Rev. Genet. 8:9-22.
64. Scobey, M. J., C. A. Fix, and W. H. Walker. 2004. The Id2 transcriptional repressor is induced by follicle-stimulating hormone and cAMP. J. Biol. Chem. 279:16064-16070.
65. Scott, G. A., and L. A. Goldsmith. 1993. Homeobox genes and skin development: a review. J. Investig. Dermatol. 101:3-8.
66. Slebos, R. J., M. H. Lee, B. S. Plunkett, T. D. Kessis, B. O. Williams, T. Jacks, L. Hedrick, M. B. Kastan, and K. R. Cho. 1994. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91:5320-5324.
67. Smedts, F., F. Ramaekers, S. Troyanovsky, M. Pruszczynski, H. Robben, B. Lane, I. Leigh, F. Plantema, and P. Vooijs. 1992. Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intra-epithelial neoplasia. Am. J. Pathol. 140:601-612.
68. Storre, J., H. P. Elsasser, M. Fuchs, D. Ullmann, D. M. Livingston, and S. Gaubatz. 2002. Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6. EMBO Rep. 3:695-700.
69. Stubenrauch, F., and L. A. Laimins. 1999. Human papillomavirus life cycle: active and latent phases. Semin. Cancer Biol. 9:379-386.
70. Takahashi, K., K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
71. Takihara, Y., D. Tomotsune, M. Shirai, Y. Katoh-Fukui, K. Nishii, M. A. Motaleb, M. Nomura, R. Tsuchiya, Y. Fujita, Y. Shibata, T. Higashinakagawa, and K. Shimada. 1997. Targeted disruption of the mouse homologue of the Drosophila polyhomeotic gene leads to altered anteroposterior patterning and neural crest defects. Development 124:3673-3682.
72. Tiberio, C., P. Barba, M. C. Magli, F. Arvelo, T. Le Chevalier, M. F. Poupon, and C. Cillo. 1994. HOX gene expression in human small-cell lung cancers xenografted into nude mice. Int. J. Cancer 58:608-615.
73. Trimarchi, J. M., B. Fairchild, R. Verona, K. Moberg, N. Andon, and J. A. Lees. 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 95:2850-2855.
74. Trimarchi, J. M., B. Fairchild, J. Wen, and J. A. Lees. 2001. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc. Natl. Acad. Sci. USA 98:1519-1524.
75. Tsutsumi, K., Q. Sun, S. Yasumoto, K. Kikuchi, Y. Ohta, A. Pater, and M. M. Pater. 1993. In vitro and in vivo analysis of cellular origin of cervical squamous metaplasia. Am. J. Pathol. 143:1150-1158.
76. Turner, B. M. 2005. Reading signals on the nucleosome with a new nomenclature for modified histones. Nat. Struct. Mol. Biol. 12:110-112.
77. van der Lugt, N. M., J. Domen, K. Linders, M. van Roon, E. Robanus-Maandag, H. te Riele, M. van der Valk, J. Deschamps, M. Sofroniew, M. van Lohuizen, et al. 1994. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 8:757-769.
78. von Mering, C., L. J. Jensen, M. Kuhn, S. Chaffron, T. Doerks, B. Kruger, B. Snel, and P. Bork. 2007. STRING 7 - recent developments in the integration and prediction of protein interactions. Nucleic Acids Res. 35:D358-D362.
79. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
80. Wells, S. I., D. A. Francis, A. Y. Karpova, J. J. Dowhanick, J. D. Benson, and P. M. Howley. 2000. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J. 19:5762-5771.
81. Werness, B. A., A. J. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
82. Wrede, D., J. A. Tidy, T. Crook, D. Lane, and K. H. Vousden. 1991. Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol. Carcinog. 4:171-175.
83. Wu, E. W., K. E. Clemens, D. V. Heck, and K. Munger. 1993. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J. Virol. 67:2402-2407.
84. Xu, X., M. Bieda, V. X. Jin, A. Rabinovich, M. J. Oberley, R. Green, and P. J. Farnham. 2007. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res. 17:1550-1561.
85. Yu, J., M. A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J. L. Frane, S. Tian, J. Nie, G. A. Jonsdottir, V. Ruotti, R. Stewart, Slukvin II, and J. A. Thomson. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
86. Zerfass-Thome, K., W. Zwerschke, B. Mannhardt, R. Tindle, J. W. Botz, and P. Jansen-Durr. 1996. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330.
87. zur Hausen, H. 2000. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690-698.